FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078839892> ?p ?o ?g. }

• W2078839892 endingPage "178" @default.
• W2078839892 startingPage "170" @default.
• W2078839892 abstract "Aim To compare safety and efficacy of insulin glargine and liraglutide in patients with type 2 diabetes (T2DM). Methods This randomized, multinational, open-label trial included subjects treated for T2DM with metformin ± sulphonylurea, who had glycated haemoglobin (HbA1c) levels of 7.5–12%. Subjects were assigned to 24 weeks of insulin glargine, titrated to target fasting plasma glucose of 4.0–5.5 mmol/L or liraglutide, escalated to the highest approved clinical dose of 1.8 mg daily. The trial was powered to detect superiority of glargine over liraglutide in percentage of people reaching HbA1c <7%. Results The mean [standard deviation (s.d.)] age of the participants was 57 (9) years, the duration of diabetes was 9 (6) years, body mass index was 31.9 (4.2) kg/m2 and HbA1c level was 9.0 (1.1)%. Equal numbers (n = 489) were allocated to glargine and liraglutide. Similar numbers of subjects in both groups attained an HbA1c level of <7% (48.4 vs. 45.9%); therefore, superiority of glargine over liraglutide was not observed (p = 0.44). Subjects treated with glargine had greater reductions of HbA1c [−1.94% (0.05) and −1.79% (0.05); p = 0.019] and fasting plasma glucose [6.2 (1.6) and 7.9 (2.2) mmol/L; p < 0.001] than those receiving liraglutide. The liraglutide group reported a greater number of gastrointestinal treatment-emergent adverse events (p < 0.001). The mean (s.d.) weight change was +2.0 (4.0) kg for glargine and −3.0 (3.6) kg for liraglutide (p < 0.001). Symptomatic hypoglycaemia was more common with glargine (p < 0.001). A greater number of subjects in the liraglutide arm withdrew as a result of adverse events (p < 0.001). Conclusion Adding either insulin glargine or liraglutide to subjects with poorly controlled T2DM reduces HbA1c substantially, with nearly half of subjects reaching target levels of 7%." @default.
• W2078839892 created "2016-06-24" @default.
• W2078839892 creator A5019816025 @default.
• W2078839892 creator A5021039903 @default.
• W2078839892 creator A5025169113 @default.
• W2078839892 creator A5028953583 @default.
• W2078839892 creator A5030986164 @default.
• W2078839892 creator A5031768361 @default.
• W2078839892 creator A5041274229 @default.
• W2078839892 creator A5071074041 @default.
• W2078839892 creator A5084404405 @default.
• W2078839892 date "2014-12-07" @default.
• W2078839892 modified "2023-10-16" @default.
• W2078839892 title "Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes" @default.
• W2078839892 cites W1966748421 @default.
• W2078839892 cites W1967256054 @default.
• W2078839892 cites W1968865647 @default.
• W2078839892 cites W1979270297 @default.
• W2078839892 cites W2007003907 @default.
• W2078839892 cites W2022069934 @default.
• W2078839892 cites W2038961236 @default.
• W2078839892 cites W2071770035 @default.
• W2078839892 cites W2081276121 @default.
• W2078839892 cites W2086177834 @default.
• W2078839892 cites W2105744242 @default.
• W2078839892 cites W2108165812 @default.
• W2078839892 cites W2111473023 @default.
• W2078839892 cites W2122994980 @default.
• W2078839892 cites W2123202603 @default.
• W2078839892 cites W2126781806 @default.
• W2078839892 cites W2137352234 @default.
• W2078839892 cites W2139485303 @default.
• W2078839892 cites W2152984355 @default.
• W2078839892 cites W2155918752 @default.
• W2078839892 cites W2159198773 @default.
• W2078839892 cites W2172193326 @default.
• W2078839892 cites W2752336761 @default.
• W2078839892 cites W97375214 @default.
• W2078839892 doi "https://doi.org/10.1111/dom.12406" @default.
• W2078839892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25359159" @default.
• W2078839892 hasPublicationYear "2014" @default.
• W2078839892 type Work @default.
• W2078839892 sameAs 2078839892 @default.
• W2078839892 citedByCount "35" @default.
• W2078839892 countsByYear W20788398922015 @default.
• W2078839892 countsByYear W20788398922016 @default.
• W2078839892 countsByYear W20788398922017 @default.
• W2078839892 countsByYear W20788398922018 @default.
• W2078839892 countsByYear W20788398922019 @default.
• W2078839892 countsByYear W20788398922020 @default.
• W2078839892 countsByYear W20788398922021 @default.
• W2078839892 countsByYear W20788398922022 @default.
• W2078839892 countsByYear W20788398922023 @default.
• W2078839892 crossrefType "journal-article" @default.
• W2078839892 hasAuthorship W2078839892A5019816025 @default.
• W2078839892 hasAuthorship W2078839892A5021039903 @default.
• W2078839892 hasAuthorship W2078839892A5025169113 @default.
• W2078839892 hasAuthorship W2078839892A5028953583 @default.
• W2078839892 hasAuthorship W2078839892A5030986164 @default.
• W2078839892 hasAuthorship W2078839892A5031768361 @default.
• W2078839892 hasAuthorship W2078839892A5041274229 @default.
• W2078839892 hasAuthorship W2078839892A5071074041 @default.
• W2078839892 hasAuthorship W2078839892A5084404405 @default.
• W2078839892 hasBestOaLocation W20788398921 @default.
• W2078839892 hasConcept C126322002 @default.
• W2078839892 hasConcept C134018914 @default.
• W2078839892 hasConcept C197934379 @default.
• W2078839892 hasConcept C2777180221 @default.
• W2078839892 hasConcept C2779306644 @default.
• W2078839892 hasConcept C2779920387 @default.
• W2078839892 hasConcept C2780323712 @default.
• W2078839892 hasConcept C2781308992 @default.
• W2078839892 hasConcept C555293320 @default.
• W2078839892 hasConcept C71924100 @default.
• W2078839892 hasConcept C90924648 @default.
• W2078839892 hasConceptScore W2078839892C126322002 @default.
• W2078839892 hasConceptScore W2078839892C134018914 @default.
• W2078839892 hasConceptScore W2078839892C197934379 @default.
• W2078839892 hasConceptScore W2078839892C2777180221 @default.
• W2078839892 hasConceptScore W2078839892C2779306644 @default.
• W2078839892 hasConceptScore W2078839892C2779920387 @default.
• W2078839892 hasConceptScore W2078839892C2780323712 @default.
• W2078839892 hasConceptScore W2078839892C2781308992 @default.
• W2078839892 hasConceptScore W2078839892C555293320 @default.
• W2078839892 hasConceptScore W2078839892C71924100 @default.
• W2078839892 hasConceptScore W2078839892C90924648 @default.
• W2078839892 hasFunder F4320307781 @default.
• W2078839892 hasIssue "2" @default.
• W2078839892 hasLocation W20788398921 @default.
• W2078839892 hasLocation W20788398922 @default.
• W2078839892 hasLocation W20788398923 @default.
• W2078839892 hasOpenAccess W2078839892 @default.
• W2078839892 hasPrimaryLocation W20788398921 @default.
• W2078839892 hasRelatedWork W1984553087 @default.
• W2078839892 hasRelatedWork W1988440435 @default.
• W2078839892 hasRelatedWork W1996010611 @default.
• W2078839892 hasRelatedWork W2062098402 @default.
• W2078839892 hasRelatedWork W2126862523 @default.

• next